Cardiovascular Mortality Risk in Patients with Bladder Cancer: A Population-Based Study

Figures

• 

  Figure 1. Selection of eligible patients and study design.

• 

  Figure 2. Causes of death in each latency period following bladder cancer diagnosis (dark blue indicates the percentage of the total number of deaths for each latency period).

• 

  Figure 3. The overall standardized mortality ratio (SMR) of all causes of death of bladder cancer patients increased year by year (A). SMR in cardiovascular disease stratified by sex (B) and all causes of cardiovascular mortality (C).

• 

  Figure 4. The overall standardized mortality ratio (SMR) of all causes of death in bladder cancer patients decreased with increasing follow-up time (A). SMR in cardiovascular disease stratified by sex (B) and all causes of cardiovascular mortality (C).

• 

  Figure 5. Independent Nelson–Aalen cumulative hazard curves for various factors of cardiovascular mortality in bladder cancer patients: age (A), sex (B), race (C), summary stage (D), surgery (E), histologic type (F), education level (G), marital status (H), and median household income (I).

• 

  Figure 6. Nelson–Aalen cumulative hazard curves for all causes of death in primary bladder cancer patients (A) and stratified by the six factors of cardiovascular disease (B).

• 

  Figure 7. Nelson–Aalen cumulative hazard curves for all causes of death in primary bladder cancer patients in different age groups: 0–50 years (A), 51–60 years (B), 61–70 years (C), 71–80 years (D), and 81+ years (E).

• 

  Figure 8. Cumulative incidence curves for various factors of cardiovascular mortality in bladder cancer patients after competing risk regression analysis: age (A), sex (B), race (C), summary stage (D), surgery (E), histologic type (F), education level (G), marital status (H), and year of diagnosis (I).